Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21

Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40...

Full description

Bibliographic Details
Main Authors: SoonHo Kweon, Minh-Trang Thi Phan, Sejong Chun, HongBi Yu, Jinho Kim, Seokho Kim, Jaemin Lee, Alaa Kassim Ali, Seung-Hwan Lee, Sang-Ki Kim, Junsang Doh, Duck Cho
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00879/full
id doaj-b506e36b528d483b8408c9de373947ed
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author SoonHo Kweon
Minh-Trang Thi Phan
Sejong Chun
HongBi Yu
Jinho Kim
Seokho Kim
Jaemin Lee
Alaa Kassim Ali
Seung-Hwan Lee
Sang-Ki Kim
Junsang Doh
Duck Cho
Duck Cho
Duck Cho
spellingShingle SoonHo Kweon
Minh-Trang Thi Phan
Sejong Chun
HongBi Yu
Jinho Kim
Seokho Kim
Jaemin Lee
Alaa Kassim Ali
Seung-Hwan Lee
Sang-Ki Kim
Junsang Doh
Duck Cho
Duck Cho
Duck Cho
Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
Frontiers in Immunology
natural killer cells
expansion
IL-21
K562
OX40 ligand
author_facet SoonHo Kweon
Minh-Trang Thi Phan
Sejong Chun
HongBi Yu
Jinho Kim
Seokho Kim
Jaemin Lee
Alaa Kassim Ali
Seung-Hwan Lee
Sang-Ki Kim
Junsang Doh
Duck Cho
Duck Cho
Duck Cho
author_sort SoonHo Kweon
title Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
title_short Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
title_full Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
title_fullStr Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
title_full_unstemmed Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
title_sort expansion of human nk cells using k562 cells expressing ox40 ligand and short exposure to il-21
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-04-01
description Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction.Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4–5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells.Results: The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation.Conclusion: Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion.
topic natural killer cells
expansion
IL-21
K562
OX40 ligand
url https://www.frontiersin.org/article/10.3389/fimmu.2019.00879/full
work_keys_str_mv AT soonhokweon expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT minhtrangthiphan expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT sejongchun expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT hongbiyu expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT jinhokim expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT seokhokim expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT jaeminlee expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT alaakassimali expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT seunghwanlee expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT sangkikim expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT junsangdoh expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT duckcho expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT duckcho expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
AT duckcho expansionofhumannkcellsusingk562cellsexpressingox40ligandandshortexposuretoil21
_version_ 1716826757704712192
spelling doaj-b506e36b528d483b8408c9de373947ed2020-11-24T20:40:30ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-04-011010.3389/fimmu.2019.00879445579Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21SoonHo Kweon0Minh-Trang Thi Phan1Sejong Chun2HongBi Yu3Jinho Kim4Seokho Kim5Jaemin Lee6Alaa Kassim Ali7Seung-Hwan Lee8Sang-Ki Kim9Junsang Doh10Duck Cho11Duck Cho12Duck Cho13School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH, Pohang, South KoreaDepartment of Mechanical Engineering, POSTECH, Pohang, South KoreaDepartment of Laboratory Medicine, Chonnam National University, GwangJu, South KoreaDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South KoreaDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South KoreaImmunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaImmunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, CanadaDepartment of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, CanadaLaboratory Animal Science, Department of Companion, Kongju National University, Yesan, South KoreaDepartment of Materials Science and Engineering, Seoul National University, Seoul, South KoreaDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea0Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South KoreaBackground: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction.Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4–5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells.Results: The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation.Conclusion: Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion.https://www.frontiersin.org/article/10.3389/fimmu.2019.00879/fullnatural killer cellsexpansionIL-21K562OX40 ligand